Novavax Q3 Earnings & Sales Beat, Stock Falls 6% on '24 View Cut
NVAX reports encouraging third-quarter results. However, the stock falls due to management lowering its sales guidance, ...
Novavax: Balancing Potential and Risk Amid Strategic Shifts and Uncertain Market Outlook
Analyst Alec Stranahan of Bank of America Securities reiterated a Hold rating on Novavax (NVAX – Research Report), reducing the price ...
MarketWatch1d
Novavax Inc. stock underperforms Tuesday when compared to competitors
Shares of Novavax Inc. NVAX slid 6.10% to $8.46 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index COMP falling 0.09% to 19,281.40 ...
Instacart Posts Earnings Beat But Stock Slips On Mixed Outlook
Instacart stock slipped late Tuesday, despite the grocery delivery company reporting a Q3 earnings and sales beat.
Novavax stock plunges after quarterly earnings, but company sees hope in licensing deals
The company now expects $650 million to $700 million in revenue for the year, down from previous guidance of $700 million to ...
Novavax sees weak Covid vaccine sales, convinced Sanofi can do better
Novavax has made a smaller splash in the U.S. Covid-19 vaccine market than it had hoped. But it's betting on licensing deals ...
Novavax, Inc. (NVAX) Q3 2024 Earnings Call Transcript
Novavax, Inc. ( NASDAQ: NVAX) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ET ...
Novavax’s stock slides 7% as guidance cut offsets narrower-than-expected third-quarter loss
NovaVax Inc.’s stock NVAX tumbled 7% early Tuesday, after the company cut its full-year guidance, offsetting a narrower-than-expected third-quarter loss and better-than-expected revenue. The company ...
Novavax falls after guidance cut on lower vaccine sales
Novavax (NVAX) stock falls 12% in premarket as company cuts full-year revenue guidance due to a lower sales outlook for its ...
Barchart on MSN2d
Stock Index Futures Fall as Trump Rally Pauses, U.S. Inflation Data and Fed Speak Awaited
December S&P 500 E-Mini futures (ESZ24) are down -0.20%, andDecember Nasdaq 100 E-Mini futures (NQZ24) are down -0.21% this ...
Business Insider2d
Novavax Resumes Phase 3 Vaccine Trials After FDA Hold
For a thorough assessment of NVAX stock, go to TipRanks’ Stock Analysis page. Trending Articles Novavax NewsMORE Related Stocks Indices Commodities Currencies Stocks ...